Prise en charge des AVC sous anticoagulants oraux

Forslund, 2018, Improved stroke prevention in atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants, Stroke, 49, 2122, 10.1161/STROKEAHA.118.021990 Steffel, 2018, The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation, Eur Heart J, 39, 1330, 10.1093/eurheartj/ehy136 Ebner, 2017, Emergency coagulation assessment during treatment with direct oral anticoagulants: limitations and solutions, Stroke, 48, 2457, 10.1161/STROKEAHA.117.017981 Rizos, 2012, Oral anticoagulants – a frequent challenge for the emergency management of acute ischemic stroke, Cerebrovasc Dis, 34, 411, 10.1159/000343655 Xian, 2017, Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation, JAMA, 317, 1057, 10.1001/jama.2017.1371 Touzé, 2018, Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants, Eur J Neurol, 25, 747-e52, 10.1111/ene.13582 Xian, 2012, Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator, JAMA, 307, 2600, 10.1001/jama.2012.6756 Xian, 2017, Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic stroke who take non-vitamin K antagonist oral anticoagulants before stroke, Circulation, 135, 1024, 10.1161/CIRCULATIONAHA.116.023940 Chausson, 2018, Reversal of vitamin K antagonist therapy before thrombolysis for acute ischemic stroke, Stroke, 49, 2526, 10.1161/STROKEAHA.118.020890 Pollack, 2017, Idarucizumab for dabigatran reversal - full cohort analysis, N Engl J Med, 377, 431, 10.1056/NEJMoa1707278 Connolly, 2016, Andexanet Alfa for acute major bleeding associated with Factor Xa Inhibitors, N Engl J Med, 375, 1131, 10.1056/NEJMoa1607887 Yamashiro, 2018, Adequate adherence to direct oral anticoagulant is associated with reduced ischemic stroke severity in patients with atrial fibrillation, J Stroke Cerebrovasc Dis L’Allinec, 2018, Safety and efficacy of mechanical thrombectomy in acute ischemic stroke of anticoagulated patients, J Neurointerventional Surg, 10.1136/neurintsurg-2017-013714 Seiffge, 2018, Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation, Lancet Neurol Easton, 2012, Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial, Lancet Neurol, 11, 503, 10.1016/S1474-4422(12)70092-3 Diener, 2018, Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke, Expert Opin Pharmacother, 19, 1597, 10.1080/14656566.2018.1515913 Dufrost, 2018, Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis, Autoimmun Rev, 17, 1011, 10.1016/j.autrev.2018.04.009 Bennaghmouch, 2018, Efficacy and safety of the use of non-vitamin K antagonist oral anticoagulants in patients with nonvalvular atrial fibrillation and concomitant aspirin therapy: a meta-analysis of randomized trials, Circulation, 137, 1117, 10.1161/CIRCULATIONAHA.117.028513 Cordonnier, 2018, Intracerebral haemorrhage: current approaches to acute management, Lancet Lond Engl, 392, 1257, 10.1016/S0140-6736(18)31878-6 Al-Shahi Salman, 2018, Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data, Lancet Neurol, 17, 885, 10.1016/S1474-4422(18)30253-9 Lioutas, 2018, Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage, Stroke, 49, 2309, 10.1161/STROKEAHA.118.021979 Steiner, 2016, Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial, Lancet Neurol, 15, 566, 10.1016/S1474-4422(16)00110-1 Murthy, 2017, Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis, Stroke, 48, 1594, 10.1161/STROKEAHA.116.016327 Pennlert, 2017, Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation, Stroke, 48, 314, 10.1161/STROKEAHA.116.014643